STOCK OPTION AGREEMENT (Director)Stock Option Agreement • August 13th, 2013 • Asterias Biotherapeutics, Inc. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledAugust 13th, 2013 Company Industry JurisdictionTHIS AGREEMENT made and entered into as of ______, 20___, by and between Asterias Biotherapeutics, Inc., a Delaware corporation (the “Company”), and _________, a director (the “Optionee”) of the Company.
ROYALTY AGREEMENTRoyalty Agreement • August 13th, 2013 • Asterias Biotherapeutics, Inc. • Biological products, (no disgnostic substances) • California
Contract Type FiledAugust 13th, 2013 Company Industry JurisdictionThis Royalty Agreement ("Agreement") is made as of _________, 2013 (“Effective Date”) by and between BioTime Acquisition Corporation, a Delaware corporation (“BAC”), and Geron Corp., a Delaware corporation (“Geron”).
EXCLUSIVE SUBLICENSE AGREEMENT between GERON CORPORATION and BIOTIME ACQUISITION CORPORATIONExclusive Sublicense Agreement • August 13th, 2013 • Asterias Biotherapeutics, Inc. • Biological products, (no disgnostic substances) • California
Contract Type FiledAugust 13th, 2013 Company Industry JurisdictionThis EXCLUSIVE SUBLICENSE AGREEMENT (the “Agreement”) is entered into as of _____________, 2013 (the “Effective Date”) by and between Geron Corporation, a Delaware corporation having a principal place of business at 149 Commonwealth Drive, Menlo Park, California 94025 (“Geron”), and BioTime Acquisition Corporation, a Delaware corporation having a principal place of business at 1301 Harbor Bay Parkway, Alameda, CA 94502 (“Licensee”). Geron and Licensee are each referred to individually herein as a “Party,” and collectively as the “Parties.”
INCENTIVE STOCK OPTION AGREEMENTIncentive Stock Option Agreement • August 13th, 2013 • Asterias Biotherapeutics, Inc. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledAugust 13th, 2013 Company Industry JurisdictionTHIS AGREEMENT made and entered into as of _______, 20__, by and between Asterias Biotherapeutics, Inc., a Delaware corporation (the “Company”), and __________, an employee (the “Employee”) of the Company.
EMPLOYMENT AGREEMENTEmployment Agreement • August 13th, 2013 • Asterias Biotherapeutics, Inc. • Biological products, (no disgnostic substances) • California
Contract Type FiledAugust 13th, 2013 Company Industry JurisdictionTHIS EMPLOYMENT AGREEMENT (“Agreement”) is made as of June 24, 2013 by and between Asterias Biotherapeutics, Inc. (“Asterias”), a Delaware corporation, and Thomas Okarma ("Executive").
EMPLOYMENT AGREEMENTEmployment Agreement • August 13th, 2013 • Asterias Biotherapeutics, Inc. • Biological products, (no disgnostic substances) • California
Contract Type FiledAugust 13th, 2013 Company Industry JurisdictionTHIS EMPLOYMENT AGREEMENT (“Agreement”) is made as of June 24, 2013 by and between Asterias Biotherapeutics, Inc. (“Asterias”), a Delaware corporation, and Dr. Jane Lebkowski ("Executive").
SUBLICENSE AGREEMENTSublicense Agreement • August 13th, 2013 • Asterias Biotherapeutics, Inc. • Biological products, (no disgnostic substances) • California
Contract Type FiledAugust 13th, 2013 Company Industry JurisdictionThis Sublicense Agreement (“Agreement”) is made and entered into as of the ____ day of ___, 2013 (the “Effective Date”), by and between BioTime, Inc., a California corporation (“BioTime”), and BioTime Acquisition Corporation, a Delaware corporation (“BAC”). BioTime and BAC are sometimes hereinafter referred to as the “Parties”.
SHARE EXCHANGE AGREEMENTShare Exchange Agreement • August 13th, 2013 • Asterias Biotherapeutics, Inc. • Biological products, (no disgnostic substances) • California
Contract Type FiledAugust 13th, 2013 Company Industry JurisdictionThis Agreement is entered into by Thomas Okarma (“Purchaser”) and BioTime Acquisition Corporation, a Delaware corporation (the “Company).